BioSpace News Archive

SphingoTec’s Innovative IVD Product sphingotest(R) penKid(R) Receives First IVDR Certificate

Diagnostic company SphingoTec has been successfully re-certified according to ISO 13485 and received its first IVDR certificate for its IVD product sphingotest® penKid®.

May 9, 2023
·
2 min read
Aiosyn, Radboud university medical center, and Pathologie-DNA are Awarded a EUR 1.300.000 EFRO Grant to Develop AI-Powered Solutions for Cancer Diagnostics

Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to accelerate the development of AI technology for breast and skin cancer diagnostics.

May 9, 2023
·
4 min read
Promore Pharma’s Annual Report 2022

The 2022 Annual report of Promore Pharma AB is now available on the Company’s website.

May 9, 2023
·
1 min read
Business

Enterome forms Scientific Advisory Board and Medical Advisory Group as it advances its OncoMimics™ immunotherapy pipeline for solid and liquid tumors

Enterome announces the creation of its international Scientific Advisory Board and Medical Advisory Group comprising highly respected and influential scientific and clinical leaders in oncology and immunotherapy.

May 9, 2023
·
7 min read
Business

BrainStorm to Announce First Quarter 2023 Financial Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. announced that it will hold a conference call to update shareholders on financial results for the First Quarter ended March 31, 2023, and provide a corporate update, at 8:00 a.m. Eastern Time on Monday, May 15th.

May 9, 2023
·
4 min read
Lone Star Bio

The Caris Precision Oncology Alliance Welcomes Yale Cancer Center

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that Yale Cancer Center has joined the Caris Precision Oncology Alliance™.

May 9, 2023
·
4 min read
Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference

Aurinia Pharmaceuticals Inc. announced data from the kidney biopsy sub-study of the AURORA clinical trial program was presented at the Congress of Clinical Rheumatology East Conference May 4 – 7, 2023.

May 9, 2023
·
9 min read
Business

IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the first quarter ended March 31, 2023.

May 9, 2023
·
30 min read
Business

Perrigo Announces Chief Executive Officer Retirement and Succession Plan

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products , today announced that Murray S. Kessler has notified the Company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023.

May 9, 2023
·
7 min read
Business

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2023, and Provide Corporate Update

Immunic, Inc. announced that the company will release its financial results for the first quarter ended March 31, 2023, including a corporate update, on Thursday, May 11, 2023, before the opening of the U.S. financial markets.

May 9, 2023
·
4 min read